Scott J. Hunter, PhD, a member of WCG’s Scientific Leadership Team, shared his insights during a recent conversation with Mark Opler, PhD, MPH, chief research officer at WCG’s MedAvante-ProPhase. Dr. Hunter is a professor of psychiatry and behavioral neuroscience, as well as pediatrics, at the University of Chicago.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Placebo Response Reduction and Accurate Pain Reporting Training Reduces Placebo Responses
WIRB-Copernicus IRB Announces New Program to Facilitate IRB Review of Research Protocols for COVID-19 (Coronavirus) Vaccines and Therapies
Basket Clinical Trial Designs The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct
Driving High Performance - Shortening study start-up and optimizing revenue generation
